Press Releases Eli Lilly and Company Borsa Italiana

Equities

4LLY

US5324571083

Real-time Estimate Tradegate Other stock markets 17:14:58 17/07/2024 BST			5-day change	1st Jan Change
838 ^EUR	-4.12%		+2.14%	+66.00%

03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT
03:38pm	Earnings reports take center stage as tech stocks tumble

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	07-12	AQ
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion - InsideArbitrage	07-10	AQ
Weight loss drug Zepbound outperforms Ozempic in new published study	07-08	AQ
Lilly agrees $3.2b IBD acquisition	07-08	AQ
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024	07-02	AQ
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	06-27	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	06-27	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	06-25	PR
Lilly Declares Third-Quarter 2024 Dividend	06-24	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	06-20	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	06-20	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	06-20	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	06-08	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	06-05	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	06-05	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	06-03	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	05-31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	05-29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm